glp-1 in cleveland GLP-1s Are More Than a Diet Fad for Patients Facing Obesity New study suggests GLP-1 drugs

The Trump administration is pushing for weight loss drug prices to come down, and Big Food players are preparing for the aftermath of changes GLP-1s will have on consumer behavior

16: Novartis and Roches Xolair became the first treatment for children and adults with one or more food allergies on Friday as the FDA approved the blockbuster to treat accidental exposure in patients one year and older with IgE-mediated food allergies

Emerging treatments for short bowel syndrome in adult patients

doi: 10.1007/s12035-016-0297-1 [DOI] [PMC free article] [PubMed] [Google Scholar] 50

Assessing the safety of sitagliptin in older participants in the trial evaluating cardiovascular outcomes with sitagliptin (TECOS)

PlexusDx supports patients through these real-world health events with clear guidance, affordable access, and personalized protocols designed for long-term success